These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17458195)

  • 1. [Risk of cardiovascular diseases in relation to insulin resistance: the Tanno-Sobetsu study].
    Saitoh S
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():59-63. PubMed ID: 17458195
    [No Abstract]   [Full Text] [Related]  

  • 2. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tanno-Sobetsu chou study].
    Shimamoto K; Miura T; Saito S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():104-7. PubMed ID: 16981528
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting cardiovascular risk: early identification of insulin resistance.
    Fortson J; Howe L; Harmon C; Sherrill WW
    J Am Acad Nurse Pract; 2008 Jun; 20(6):319-25. PubMed ID: 18588659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome is associated with subclinical atherosclerosis independent of insulin resistance: the Guangzhou Biobank Cohort Study-CVD.
    Xu L; Jiang CQ; Lam TH; Lin JM; Yue XJ; Cheng KK; Liu B; Jin YL; Zhang WS; Thomas GN;
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):181-8. PubMed ID: 20039893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance syndrome: a potent culprit in cardiovascular disease.
    Coulston AM; Peragallo-Dittko V
    J Am Diet Assoc; 2004 Feb; 104(2):176-9. PubMed ID: 14760563
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathogenesis and etiology of cardiovascular disease: role of insulin resistance].
    Takahashi A; Kushiro T
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():163-8. PubMed ID: 17458212
    [No Abstract]   [Full Text] [Related]  

  • 9. [The Tanno and Sobetsu study].
    Ohnishi H; Saitoh S; Shimamoto K
    Nihon Rinsho; 2010 May; 68(5):839-42. PubMed ID: 20446579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of intraocular pressure with the metabolic syndrome and novel cardiometabolic risk factors.
    Chang YC; Lin JW; Wang LC; Chen HM; Hwang JJ; Chuang LM
    Eye (Lond); 2010 Jun; 24(6):1037-43. PubMed ID: 19816514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea.
    Tkacova R; Dorkova Z; Molcanyiova A; Radikova Z; Klimes I; Tkac I
    Med Sci Monit; 2008 Sep; 14(9):CR438-44. PubMed ID: 18758413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk.
    Bergman RN; Kim SP; Hsu IR; Catalano KJ; Chiu JD; Kabir M; Richey JM; Ader M
    Am J Med; 2007 Feb; 120(2 Suppl 1):S3-8; discussion S29-32. PubMed ID: 17296343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome and the postmenopausal woman.
    Ireland K; Child T
    J Br Menopause Soc; 2006 Dec; 12(4):143-8. PubMed ID: 17178014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome.
    Chang CJ; Yang YC; Lu FH; Lin TS; Chen JJ; Yeh TL; Wu CH; Wu JS
    Am J Med; 2010 May; 123(5):432-8. PubMed ID: 20399320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now?
    Sattar N
    Minerva Endocrinol; 2005 Sep; 30(3):121-38. PubMed ID: 16208304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome and its cardiovascular manifestations.
    Sánchez-Torres RJ; Delgado-Osorio H
    Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance, metabolic syndrome and endothelial dysfunction.
    Bigazzi R; Bianchi S
    J Nephrol; 2007; 20(1):10-4. PubMed ID: 17347967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome: is it a syndrome? Does it matter?
    Kahn R
    Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.